LAGE Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of LAGE Antibodies for research in immunology and cancer biology. LAGE Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LAGE (L antigen family member 1) is a cancer/testis antigen that plays a significant role in tumor immunology, making it a key target for cancer immunotherapy. LAGE expression is typically restricted to germ cells in the testis and is aberrantly expressed in various tumors, highlighting its potential as a biomarker for cancer diagnosis and treatment. Understanding LAGE expression patterns helps researchers identify potential therapeutic targets in different cancer types. Investigating LAGE can reveal important mechanisms in tumor development and progression. Research into LAGE contributes to our understanding of immune responses in cancer. LAGE studies are advancing the development of targeted cancer treatments. Santa Cruz Biotechnology monoclonal antibodies for LAGE research support scientists worldwide in developing innovative cancer therapies and diagnostic tools.